![Patent Cybin Patent](https://psychedelicmedicalnews.com/wp-content/uploads/2024/02/Patent-500x300.jpg)
Cybin
![Patent Cybin Patent](https://psychedelicmedicalnews.com/wp-content/uploads/2024/02/Patent-500x300.jpg)
![Anxiety Cybin CYB004 Anxiety](https://psychedelicmedicalnews.com/wp-content/uploads/2024/01/Anxiety-500x300.jpg)
Cybin Receives FDA Clearance to Initiate Phase 2a Study of DMT Molecule for Anxiety
![Cybin-DMT Cybin Deuterated DMT](https://psychedelicmedicalnews.com/wp-content/uploads/2024/01/Cybin-DMT-500x300.jpg)
Cybin Reports Positive Top-Line Results for Deuterated DMT Molecules
Cybin: Psilocybin Trial Participants Experience Nearly 80% Reduction in Depression Symptoms
![Doug-Drysdale-Cybin Doug Drysdale](https://psychedelicmedicalnews.com/wp-content/uploads/2023/12/Doug-Drysdale-Cybin-500x300.jpg)
Cybin: CYB003 Achieves ‘Primary Efficacy Endpoint’ in Phase 2 Study
![Cybin briefing Cybin briefing](https://psychedelicmedicalnews.com/wp-content/uploads/2023/11/Cybin-briefing-1024x576-500x300.jpg)